Champions Oncology

Champions Oncology, Inc. develops and sells technology solutions and products aimed at personalizing oncology drug development and treatment. Central to its offerings is the Tumorgraft Technology Platform, which involves implanting human tumors in immune-deficient mice to derive personalized treatment options based on tumor-specific data. The company provides Personalized Oncology Solutions (POS) to assist physicians in tailoring cancer therapies through drug panels and related services, as well as Translational Oncology Solutions (TOS) that help pharmaceutical and biotechnology firms in their drug development processes. Champions Oncology's products, including TumorGraft implants and drug panels, are marketed to patients and healthcare providers through various channels. Founded by leading experts in oncology, the company was established in 1985 and is headquartered in Hackensack, New Jersey.